Zenas BioPharma (ZBIO) Change in Cash (2023 - 2026)

Zenas BioPharma's Change in Cash history runs 4 years deep, the most recent figure standing at $389.6 million for Q1 2026.

• In Q1 2026, Change in Cash rose 416.02% year-over-year to $389.6 million; the TTM figure through Mar 2026 stood at $303.7 million (up 90.61% YoY), while the FY2025 annual figure was -$209.2 million, down 179.57% from the prior year.
• Change in Cash was $389.6 million for Q1 2026 at Zenas BioPharma, up from -$4.9 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $389.6 million in Q1 2026 to a low of -$152.5 million in Q2 2025.
• Historically, Change in Cash has averaged $42.8 million across 4 years, with a median of -$10.2 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Change in Cash sank 525.71% in 2025, then soared 416.02% in 2026.
• A 4-year view of Change in Cash shows it stood at -$15.5 million in 2023, then plunged by 160.74% to -$40.3 million in 2024, then soared by 87.78% to -$4.9 million in 2025, then surged by 8011.92% to $389.6 million in 2026.
• The last three Change in Cash figures came in at $389.6 million (Q1 2026), -$4.9 million (Q4 2025), and $71.6 million (Q3 2025), per Business Quant data.